Skip to main content
Aprogen, Inc logo

Aprogen, Inc — Investor Relations & Filings

Ticker · 007460 ISIN · KR7007460009 KO Manufacturing
Open in API
Filings indexed 735 across all filing types
Latest filing 2022-11-18 Major Shareholding Noti…
Country KR South Korea
Listing KO 007460

About Aprogen, Inc

https://www.aprogen.com/en/v.do?a=Main

Aprogen, Inc. is a biopharmaceutical company focused on the research, development, and manufacturing of biologic medicines. The company's core activities are centered on developing both biosimilars and novel drugs, including new protein therapeutics and bispecific antibodies. Its product development is based on proprietary technologies in antibody engineering and recombinant protein engineering.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Major Shareholding Notification Classification · 100% confidence The document is a Korean regulatory filing titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a standard disclosure form required by the Financial Supervisory Service (FSS) in South Korea when a major shareholder or executive changes their stake in a company. This falls under the category of 'Major Shareholding Notification' (MRQ) as it details the change in share ownership percentage by a major shareholder (G-Base Inc.) in the issuing company (Aprogen).
2022-11-18 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. This document details changes in share ownership (crossing thresholds) by a major shareholder (G-Base) and its special related parties in the company 'Aprogen'. This falls under the 'Major Shareholding Notification' category.
2022-11-18 Korean
최대주주등소유주식변동신고서
Major Shareholding Notification Classification · 100% confidence The document is a '최대주주등소유주식변동신고서' (Report on Changes in Shareholding by Major Shareholders, etc.). This filing details changes in the number of shares held by the company's major shareholders and related parties, including specific transaction dates, reasons for changes (e.g., off-market sales, resignation), and updated ownership percentages. This falls under the category of Major Shareholding Notification (MRQ), as it tracks significant changes in ownership levels by major stakeholders.
2022-11-18 Korean
[기재정정]타법인주식및출자증권취득결정
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from a Korean company (Aprogen) regarding the acquisition of shares in another company (Aprogen Pharmaceutical). It is a formal 'Correction Report' (정정신고) detailing changes to the acquisition date and payment schedule. This type of corporate action, involving the acquisition of equity in another entity, falls under M&A activity or significant corporate investment announcements. Given the specific categories provided, 'TAR' (M&A Activity) is the most appropriate classification for documents detailing the acquisition of shares in other companies.
2022-11-18 Korean
[기재정정]주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 100% confidence The document is a 'Major Matters Report' (주요사항보고서) regarding the 'Decision to Issue Convertible Bonds' (전환사채권 발행결정) and specifically acts as a 'Correction Report' (정정신고) for a previously filed report. It details changes to bond maturity dates, interest payment methods, conversion prices, and other financial terms related to capital raising. This falls under the category of company financing and capital structure updates.
2022-11-18 Korean
[기재정정]유상증자결정(종속회사의주요경영사항)
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from a Korean company (Aprogen) regarding a 'Capital Increase Decision' (유상증자결정) for its subsidiary. It details the issuance of new shares, the purpose of the funds (operating capital), the method (third-party allocation), and includes a correction notice regarding the payment date. This falls under the category of share issuance and capital changes.
2022-11-18 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.